Furmonertinib treatment in patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastases: A real-world study

被引：0
|
作者：
Chen, H.
Wang, L.
Wu, Y.
Wu, Y.
Ma, S.
Sen, Y.
Zhen, H.
Mo, Y.
Zhang, C.
Wang, Q.
机构：
[1] Zhengzhou Univ, Affiliated Canc Hosp, Dept Internal Med, Zhengzhou, Peoples R China
[2] Henan Canc Hosp, Zhengzhou, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.660
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
582P
引用
收藏
页码：S1697 / S1697
页数：1
相关论文
共 50 条
  • [41] Treatment Patterns, Clinical Outcomes and Health Care Resource Utilisation in Patients with EGFR-mutated Metastatic Non-Small Cell Lung Cancer: A Real-World Study in South Korea
    Cliff Molife
    Jae Min Cho
    Jennifer Lapthorn
    Min Ju Kang
    Yulia D’yachkova
    Sangmi Kim
    Sam Colman
    Saerom Kim
    Agota Szende
    Ji Hyun Park
    Hee Kyung Ahn
    Min Hee Hong
    Kaisa-Leena Taipale
    Hye Ryun Kim
    Drugs - Real World Outcomes, 2023, 10 : 131 - 143
  • [42] Progress in individualized treatment for EGFR-mutated advanced non-small cell lung cancer
    Inoue, Akira
    PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES, 2020, 96 (07): : 266 - 272
  • [43] Mutated TP53 prevalence in EGFR-mutated advanced non-small cell lung cancer patients with brain metastases
    Stensgaard, Simone
    Eide, Inger Johanne Z.
    Stensland, Elin Marie
    Helland, Aslaug
    Ekman, Simon
    Hansen, Karin H.
    Cicenas, Saulius
    Gronberg, Bjorn Henning
    Meldgaard, Peter
    Sorensen, Boe S.
    Brustugun, Odd Terje
    CANCER RESEARCH, 2024, 84 (06)
  • [44] Efficacy of Tyrosine Kinase Inhibitors in EGFR Mutated Non-Small Cell Lung Cancer with Leptomeningeal Metastases
    Flippot, R.
    Auclin, E.
    Biondani, P.
    Le Rhun, E.
    Adam, J.
    Planchard, D.
    Caramella, C.
    Le Pechoux, C.
    Lacroix, L.
    Gazzah, A.
    Mezquita, L.
    Besse, B.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S467 - S467
  • [45] Role of exosomes in non-small cell lung cancer and EGFR-mutated lung cancer
    Rao, Ding-Yu
    Huang, De-Fa
    Si, Mao-Yan
    Lu, Hua
    Tang, Zhi-Xian
    Zhang, Zu-Xiong
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [46] Capmatinib plus nazartinib in patients with EGFR-mutated non-small cell lung cancer
    Felip, Enriqueta
    Metro, Giulio
    Soo, Ross A.
    Wolf, Juergen
    Solomon, Benjamin J.
    Tan, Daniel S. W.
    Ardizzoni, Andrea
    Lee, Dae Ho
    Sequist, Lecia V.
    Barlesi, Fabrice
    Ponce-Aix, Santiago
    Abreu, Delvys Rodriguez
    Campelo, Maria Rosario Garcia
    Sprauten, Mette
    Djentuh, Leslie O'Sullivan
    Smith, Nathalie
    Jary, Aline
    Belli, Riccardo
    Glaser, Sabine
    Zou, Mike
    Cui, Xiaoming
    Giovannini, Monica
    Yang, James Chih-Hsin
    EUROPEAN JOURNAL OF CANCER, 2024, 208
  • [47] IMAGING FEATURES OF LEPTOMENINGEAL METASTASES OF NON-SMALL CELL LUNG CANCER: A SINGLE-CENTER REAL-WORLD STUDY
    Zhen, Junjie
    Wen, Lei
    Li, Shaoqun
    Lai, Mingyao
    Shan, Changguo
    Cai, Linbo
    NEURO-ONCOLOGY, 2020, 22 : 41 - 41
  • [48] Real-World T790M Mutation Frequency and Impact of Rebiopsy in Patients With EGFR-Mutated Advanced Non-Small Cell Lung Cancer
    Pereira, Isabel
    Gaspar, Catia
    Pina, Marta
    Azevedo, Isabel
    Rodrigues, Ana
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (12)
  • [49] Optimizing Treatment Strategies for Egfr-Mutated Non-Small-Cell Lung Cancer Treated with Osimertinib: Real-World Outcomes and Insights
    Thomas, Quentin Dominique
    Girard, Nicolas
    Bosquet, Lise
    Cavaillon, Sarah
    Filleron, Thomas
    Eltaief, Siham
    Chouaid, Christos
    Lena, Herve
    Debieuvre, Didier
    Perol, Maurice
    Quantin, Xavier
    CANCERS, 2024, 16 (21)
  • [50] Clinical efficacy and safety analysis of aumolertinib in real-world treatment of EGFR-mutated advanced non-small-cell lung cancer
    Zhang, Xiaojuan
    Zhang, Mina
    Du, Xinyang
    Zhang, Guowei
    Niu, Yuanyuan
    Wei, Chunhua
    Guo, Lanwei
    Shi, Chao
    Liu, Hangfan
    Wang, Huijuan
    FRONTIERS IN PHARMACOLOGY, 2024, 15
12345